227 Patient pre-selection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa

Authors :: S. Duchatelet
Sonia Gaucher
Su M. Lwin
Alain Hovnanian
C. Ganier
Alya Abdul-Wahab
S. Miskinyte
N. Pironon
M. Titeux
John A. McGrath
Source :: Journal of Investigative Dermatology. 137:S231
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: medicine.medical_specialty
business.industry
Genetic enhancement
Cell Biology
Dermatology
Biochemistry
Phase i ii
Recessive dystrophic epidermolysis bullosa
Medicine
Pre selection
business
Molecular Biology
Ex vivo

Full Text Access

Tools